Alpha-smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity
Overview
Molecular Biology
Authors
Affiliations
To evaluate whether alpha-smooth muscle actin (alpha-SMA) plays a role in fibroblast contractility, we first compared the contractile activity of rat subcutaneous fibroblasts (SCFs), expressing low levels of alpha-SMA, with that of lung fibroblasts (LFs), expressing high levels of alpha-SMA, with the use of silicone substrates of different stiffness degrees. On medium stiffness substrates the percentage of cells producing wrinkles was similar to that of alpha-SMA-positive cells in each fibroblast population. On high stiffness substrates, wrinkle production was limited to a subpopulation of LFs very positive for alpha-SMA. In a second approach, we measured the isotonic contraction of SCF- and LF-populated attached collagen lattices. SCFs exhibited 41% diameter reduction compared with 63% by LFs. TGFbeta1 increased alpha-SMA expression and lattice contraction by SCFs to the levels of LFs; TGFbeta-antagonizing agents reduced alpha-SMA expression and lattice contraction by LFs to the level of SCFs. Finally, 3T3 fibroblasts transiently or permanently transfected with alpha-SMA cDNA exhibited a significantly higher lattice contraction compared with wild-type 3T3 fibroblasts or to fibroblasts transfected with alpha-cardiac and beta- or gamma-cytoplasmic actin. This took place in the absence of any change in smooth muscle or nonmuscle myosin heavy-chain expression. Our results indicate that an increased alpha-SMA expression is sufficient to enhance fibroblast contractile activity.
Moody A, Bhattarai N ACS Omega. 2025; 10(5):4427-4441.
PMID: 39959067 PMC: 11822518. DOI: 10.1021/acsomega.4c07504.
Comparison of dermal and eschar fibroblasts in full skin equivalents.
Kutluoglu G, Vlig M, Elgersma A, Boekema B, Daamen W, Doberenz C Wound Repair Regen. 2025; 33(1):e70001.
PMID: 39943668 PMC: 11822215. DOI: 10.1111/wrr.70001.
Armansyah T, Husnurrizal H, Wahyuni S, Hafizuddin H, Siregar T, Sutriana A Open Vet J. 2025; 14(12):3474-3486.
PMID: 39927354 PMC: 11799637. DOI: 10.5455/OVJ.2024.v14.i12.31.
Meloni M, de Rooij B, Janssen F, Rescigno F, Lombardi B Pharmaceutics. 2025; 16(12.
PMID: 39771518 PMC: 11728803. DOI: 10.3390/pharmaceutics16121539.
Tunable Bicontinuous Macroporous Cell Culture Scaffolds via Kinetically Controlled Phase Separation.
Dudaryeva O, Cousin L, Krajnovic L, Grobli G, Sapkota V, Ritter L Adv Mater. 2025; 37(7):e2410452.
PMID: 39745118 PMC: 11837887. DOI: 10.1002/adma.202410452.